(Q44420847)

2 December 2017

title

Antipruritic effects of pimecrolimus and tacrolimus (English)

1 reference

reason for deprecated rank

2 December 2017

Antipruritische Wirkung von Pimecrolimus und Tacrolimus (German)

marking inconsistent with the registered/official identifier/name

1 reference

https://api.crossref.org/works/10.1007/S00105-003-0521-6

28 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00105-003-0521-6

28 December 2023

1

S. Ständer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12719860

28 December 2023

author name string

T. A. Luger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12719860

28 December 2023

language of work or name

German

0 references

publication date

21 March 2003

1 reference

full work available at URL

2 December 2017

http://link.springer.com/content/pdf/10.1007/s00105-003-0521-6.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S00105-003-0521-6

http://link.springer.com/article/10.1007/s00105-003-0521-6/fulltext.html

28 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00105-003-0521-6

http://link.springer.com/content/pdf/10.1007/s00105-003-0521-6

28 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00105-003-0521-6

28 December 2023

1 reference

2 December 2017

volume

54

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

413-417

1 reference

Successful treatment of anogenital lichen sclerosus with topical tacrolimus

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Polymethylmethacrylate efficacy in reduction of renal itching in hemodialysis patients: crossover study and role of tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

FK 506 ointment 0.1 % - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Pathophysiology of pruritus in atopic dermatitis: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Treatment of prurigo nodularis with topical capsaicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-003-0521-6

Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.

21 January 2018

1 reference

12 December 2020

Pruritus - Pathophysiologie, Klinik und Therapie - Eine Ubersicht. Pruritus - pathophysiology, clinical features and therapy - an overview

1 reference

12 December 2020

Tacrolimus ointment for atopic dermatitis

1 reference

12 December 2020

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group

1 reference

12 December 2020

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group

1 reference

12 December 2020

Distinct serum cytokines in AIDS-related skin diseases

1 reference

12 December 2020

Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis

1 reference

12 December 2020

The treatment of atopic dermatitis with topical immunomodulators

1 reference

12 December 2020

Anti-inflammatory effect of FK-506 on human skin mast cells

1 reference

12 December 2020

Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981

1 reference

12 December 2020

Short-term efficacy of tacrolimus ointment in severe uremic pruritus

1 reference

12 December 2020

Identifiers

1 reference

2 December 2017

1 reference